Yes. If the HPV sample is obtained vaginally and can be mapped to an appropriate code in the value sets, it may be used to meet criteria.
**This FAQ applies to HEDIS Volume 2 MY 2026 & MY 2027.
Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can ask a question through My NCQA.
When the measures were released, standardized codes were not available. Therefore, the measure looks for any “not null” value which allows organizations to use their own internal proprietary codes for MY 2027 reporting.
Standardized codes for the recommended goal domains became available in the September 2026 release of SNOMED CT United States Edition. We anticipate the codes will be added to the measures for optional use in HEDIS MY 2028.
No. For HPA 2027, NCQA reviews and scores AI 1-3 and assigns points. However, those points do not count towards the organization's Accreditation status, and no minimum score (e.g., 80% of points) is required for the AI category. An organization will not be denied Accreditation, or receive a lower status, based on its performance on the AI standards.
NCQA will use what it learns from the 2027 AI standards to refine evidence expectations and scoring for future years.
Note: This FAQ clarifies the scoring language in the HPA 2027 Policies and Procedures, including the note on scoring of the AI standards.
Applicable standards:
FAQ ID #26413
No, while two standardized tobacco use screening questions exist and are included in the Tobacco Use Screening value set, use of a standardized question is not required. A direct reference code (LOINC code 72166-2) and a code in the Tobacco Use Screening Value Set (LOINC code 39240-7) can be used to document tobacco use status without using a standardized screening question. Organizations should use the option that most accurately describes the person’s tobacco use status.
Using Medicare CAHPS data in HPR depends on yearly approval by the Centers for Medicare & Medicaid Services (CMS). Because the submission schedule for Medicare CAHPS measures differs from the HEDIS submission schedule, NCQA scores organizations using the previous year’s data and percentiles for measures in the CAHPS domain.
There are also calculation differences between NCQA’s Medicare CAHPS and CMS. For example, NCQA scores some items based on a two-question composite where CMS uses a three-question composite. CMS case-mixes CAHPS results, NCQA does not. NCQA uses top-box scoring for HPR, CMS uses linear mean scoring converted from a 0-100 scale.
HPR utilizes HEDIS and CAHPS datasets, and Measurement Years can vary based on product line. To find specific information on each HPR year, please access that year's Measure List by navigating to NCQA’s Health Plan Ratings site.
"1" = Race/Ethnicity Description of Membership and Language Description of Membership
"1” = Process measures (e.g., screenings, visits)
“1.5” = Patient experience measures (CAHPS)
“3” = Outcome and intermediate outcome measures (e.g., Glycemic Status <8%, Blood Pressure Control)
The overall rating is the weighted average of a plan's HEDIS and CAHPS measure ratings, plus Accreditation bonus points (if the plan is Accredited by NCQA as of the last business day in June of the release year), calculated on a 0–5 scale in half-points (5 is highest), displayed as stars and rounded to the nearest half-point.
NCQA will give organizations credit (an individual measure rating of “5”) if the reported “Total Known” Preferred Written Language and “Total Known” Preferred Spoken Language is ≥25%. Organizations that do not report “Total Known” Preferred Written Language and “Total Known” Preferred Spoken Language ≥25% will receive an individual measure rating of “0”. The measure has a weight of 1.0.
NCQA will give organizations credit (an individual measure rating of “5”) if both reported Direct Race and Direct Ethnicity is ≥25%. Organizations that do not report Direct Race and Direct Ethnicity ≥25% will receive an individual measure rating of “0”. The measure has a weight of 1.0.
The CCS-E measure allows at-home, self-collected HPV vaginal samples that are sent to a laboratory or provider's office for analysis (see General Guideline: Self-Collected Samples). Organizations can identify qualifying screenings through multiple approved data sources, including claims, laboratory data, electronic clinical data and medical records. The absence of a specific code does not exclude identification of a qualifying screening if the organization can demonstrate numerator compliance using an approved data source that meets the requirements of the measure.
When using supplemental data (e.g., laboratory data, electronic clinical data or medical record documentation) to assess the numerator (i.e., the provider did not bill one of the codes in the measure), the documentation must meet the requirements outlined in General Guideline: Supplemental Data. NCQA does not approve code mapping, and the auditor will determine whether the data meet the intent of the measure.
If a laboratory bills for the test using any of the CPT codes in the High Risk HPV Lab Test Value Set then this meets numerator criteria. The CPT codes are not specific to sample type (vaginal versus cervical) therefore billing is based on the specific assay and types being detected by the laboratory.
**This FAQ applies to HEDIS Volume 2 MY 2026 & MY 2027.
No, because new LOINC codes were released after publication of MY 2026, organizations can use supplemental data to meet the numerator requirements. The documentation must meet the requirements outlined in General Guideline: Supplemental Data. NCQA does not approve code mapping, and the auditor will determine whether the data meet the intent of the measure.
New codes for self-collected specimens were included in LOINC’s recent release and additional pre-release codes are currently published on the LOINC website (and will be included in the next LOINC release). NCQA will review and include appropriate codes in the MY 2027 Technical Update release scheduled for March 31, 2027.
**This FAQ applies to HEDIS Volume 2 MY 2026 & MY 2027.